Brian Adams Relay Therapeutics, Inc. (RLAY) insider trading activity

Brian Adams is Chief Legal Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 371,472 shares of RLAY, which is worth approximately $2.46 Million. The most recent transaction as insider was on Jul 29, 2025, when has been sold 18,276 shares (Common Stock) at a price of $3.68 per share, resulting in proceeds of $67,255. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K

0% 3M change

15.4% 12M change

Total Value Held $2.46 Million

Brian Adams Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2025	SELL Open market or private sale	$67,255 $3.68 p/Share	18,276 Reduced 4.69%	371,472 Common Stock
Jul 28 2025	SELL Open market or private sale	$6,122 $3.74 p/Share	1,637 Reduced 0.42%	389,748 Common Stock
Apr 30 2025	SELL Open market or private sale	$38,829 $3.0 p/Share	12,943 Reduced 3.2%	391,385 Common Stock
Apr 28 2025	SELL Open market or private sale	$5,211 $3.17 p/Share	1,644 Reduced 0.4%	404,328 Common Stock
Mar 27 2025	SELL Open market or private sale	$846 $2.84 p/Share	298 Reduced 0.07%	405,972 Common Stock
Jan 30 2025	SELL Open market or private sale	$91,896 $4.42 p/Share	20,791 Reduced 4.87%	406,270 Common Stock
Jan 28 2025	SELL Open market or private sale	$155,975 $4.63 p/Share	33,688 Reduced 10.47%	287,920 Common Stock

Jan 28 2025	BUY Grant, award, or other acquisition	-	139,141 Added 24.57%	427,061 Common Stock
Dec 27 2024	SELL Open market or private sale	$1,309 $4.38 p/Share	299 Reduced 0.09%	321,608 Common Stock
Oct 28 2024	SELL Open market or private sale	$9,889 $6.06 p/Share	1,632 Reduced 0.5%	321,907 Common Stock
Sep 27 2024	SELL Open market or private sale	$2,215 $7.51 p/Share	295 Reduced 0.09%	323,539 Common Stock
Jul 29 2024	SELL Open market or private sale	$14,496 $8.85 p/Share	1,638 Reduced 0.5%	323,834 Common Stock
Jun 27 2024	SELL Open market or private sale	$1,846 $6.26 p/Share	295 Reduced 0.09%	325,472 Common Stock
Apr 29 2024	SELL Open market or private sale	$10,354 $6.38 p/Share	1,623 Reduced 0.5%	325,767 Common Stock
Mar 27 2024	SELL Open market or private sale	$2,679 $7.7 p/Share	348 Reduced 0.11%	327,390 Common Stock
Jan 29 2024	SELL Open market or private sale	$18,595 $9.64 p/Share	1,929 Reduced 0.59%	327,738 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	200,000 Added 37.76%	329,667 Common Stock
Dec 27 2023	SELL Open market or private sale	$3,383 $11.51 p/Share	294 Reduced 0.23%	129,667 Common Stock
Oct 30 2023	SELL Open market or private sale	$9,840 $6.03 p/Share	1,632 Reduced 1.24%	129,961 Common Stock
Sep 27 2023	SELL Open market or private sale	$2,463 $8.38 p/Share	294 Reduced 0.22%	131,593 Common Stock
Jul 28 2023	SELL Open market or private sale	$19,210 $11.8 p/Share	1,628 Reduced 1.22%	131,887 Common Stock
Jun 27 2023	SELL Open market or private sale	$3,563 $12.12 p/Share	294 Reduced 0.22%	133,515 Common Stock
Apr 28 2023	SELL Open market or private sale	$9,631 $11.16 p/Share	863 Reduced 0.64%	134,882 Common Stock
Mar 27 2023	SELL Open market or private sale	$5,329 $15.36 p/Share	347 Reduced 0.25%	135,745 Common Stock
Jan 30 2023	SELL Open market or private sale	$18,627 $21.56 p/Share	864 Reduced 0.63%	136,092 Common Stock

Also insider at

KYMR

Kymera Therapeutics, Inc. Healthcare

Chief Legal Officer

Brian Adams

Chief Legal Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Value

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Relay Therapeutics, Inc.

Track Activities on RLAY

Account